The growth of siRNA-based therapeutics: Updated clinical studies
MM Zhang, R Bahal, TP Rasmussen… - Biochemical …, 2021 - Elsevier
More than two decades after the natural gene-silencing mechanism of RNA interference was
elucidated, small interfering RNA (siRNA)-based therapeutics have finally broken into the …
elucidated, small interfering RNA (siRNA)-based therapeutics have finally broken into the …
Therapeutic siRNA: state of the art
ABSTRACT RNA interference (RNAi) is an ancient biological mechanism used to defend
against external invasion. It theoretically can silence any disease-related genes in a …
against external invasion. It theoretically can silence any disease-related genes in a …
The molecular basis of retinal ganglion cell death in glaucoma
M Almasieh, AM Wilson, B Morquette… - Progress in retinal and …, 2012 - Elsevier
Glaucoma is a group of diseases characterized by progressive optic nerve degeneration that
results in visual field loss and irreversible blindness. A crucial element in the …
results in visual field loss and irreversible blindness. A crucial element in the …
The race of 10 synthetic RNAi-based drugs to the pharmaceutical market
R Titze-de-Almeida, C David… - Pharmaceutical …, 2017 - Springer
Ten years after Fire and Melo's Nobel Prize for discovery of gene silencing by double-
stranded RNA, a remarkable progress was achieved in RNA interference (RNAi). Changes …
stranded RNA, a remarkable progress was achieved in RNA interference (RNAi). Changes …
[HTML][HTML] Stem cell treatment of degenerative eye disease
Stem cell therapies are being explored extensively as treatments for degenerative eye
disease, either for replacing lost neurons, restoring neural circuits or, based on more recent …
disease, either for replacing lost neurons, restoring neural circuits or, based on more recent …
Retinal ganglion cell repopulation for vision restoration in optic neuropathy: a roadmap from the RReSTORe Consortium
JR Soucy, EA Aguzzi, J Cho, MJ Gilhooley… - Molecular …, 2023 - Springer
Retinal ganglion cell (RGC) death in glaucoma and other optic neuropathies results in
irreversible vision loss due to the mammalian central nervous system's limited regenerative …
irreversible vision loss due to the mammalian central nervous system's limited regenerative …
Insulin restores retinal ganglion cell functional connectivity and promotes visual recovery in glaucoma
S El Hajji, Y Shiga, N Belforte, YC Solorio, O Tastet… - Science …, 2024 - science.org
Dendrite pathology and synaptic loss result in neural circuit dysfunction, a common feature
of neurodegenerative diseases. There is a lack of strategies that target dendritic and …
of neurodegenerative diseases. There is a lack of strategies that target dendritic and …
[HTML][HTML] Intravitreally transplanted dental pulp stem cells promote neuroprotection and axon regeneration of retinal ganglion cells after optic nerve injury
B Mead, A Logan, M Berry, W Leadbeater… - … & visual science, 2013 - arvojournals.org
Purpose.: To investigate the potential therapeutic benefit of intravitreally implanted dental
pulp stem cells (DPSCs) on axotomized adult rat retinal ganglion cells (RGCs) using in vitro …
pulp stem cells (DPSCs) on axotomized adult rat retinal ganglion cells (RGCs) using in vitro …
RNA-targeting strategies as a platform for ocular gene therapy
Genetic medicine is offering hope as new therapies are emerging for many previously
untreatable diseases. The eye is at the forefront of these advances, as exemplified by the …
untreatable diseases. The eye is at the forefront of these advances, as exemplified by the …
The role of caspase-2 in regulating cell fate
V Vigneswara, Z Ahmed - Cells, 2020 - mdpi.com
Caspase-2 is the most evolutionarily conserved member of the mammalian caspase family
and has been implicated in both apoptotic and non-apoptotic signaling pathways, including …
and has been implicated in both apoptotic and non-apoptotic signaling pathways, including …